You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 264 No. 18, November 14, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aspirin Increases Blood Alcohol Concentrations in Humans After Ingestion of Ethanol

Risto Roine, MD; R. Thomas Gentry, PhD; Rolando Hernández-Munõz, MD; Enrique Baraona, MD; Charles S. Lieber, MD

JAMA. 1990;264(18):2406-2408.


Abstract

Gastric first-pass metabolism of ethanol is an important determinant of blood alcohol concentrations. We studied five healthy volunteers after ingestion of ethanol (0.3 g/kg of body weight) and found that blood alcohol concentrations in the fed state (ie, 1 hour after a standard breakfast) were significantly higher when the subjects received 1 g of aspirin 1 hour before ingestion of ethanol than without the drug. In vitro, aspirin clearly decreased the activity of gastric alcohol dehydrogenase in human subjects and in rat models, but not that of hepatic alcohol dehydrogenase in rats. Furthermore, blood alcohol concentrations in rats were unaffected by ingestion of aspirin when ethanol was infused intravenously. Thus, aspirin may increase the bioavailability of ingested ethanol in humans, possibly by reducing ethanol oxidation by gastric alcohol dehydrogenase.

(JAMA. 1990;264:2406-2408)



Author Affiliations

From the Section of Liver Diseases and Nutrition and the Alcohol Research and Treatment Center, Bronx Veterans Administration Medical Center and Mount Sinai School of Medicine, New York, NY. Dr Hernández-Munõz is now with the Departemento de Bioenergetica, Centro de Investigaciones en Fisiologia Celular, Universidad Nacional Autonoma de Mexico, Mexico City.


Footnotes

Reprint requests to Alcohol Research and Treatment Center (151/G), Veterans Administration Medical Center, 130 W Kingsbridge Rd, Bronx, NY 10468 (Dr Lieber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Application of a Physiologically Based Pharmacokinetic Model to Estimate the Bioavailability of Ethanol in Male Rats: Distinction between Gastric and Hepatic Pathways of Metabolic Clearance
Pastino and Conolly
Toxicol Sci 2000;55:256-265.
ABSTRACT | FULL TEXT  

Inhibition of Prostaglandin Synthesis and Effects of Ethanol and Pentobarbital in Humans
Pickworth et al.
J. Pharmacol. Exp. Ther. 1997;283:274-280.
ABSTRACT | FULL TEXT  

Medical Disorders of Alcoholism
Lieber
NEJM 1995;333:1058-1065.
FULL TEXT  

ASPIRIN INCREASES ALCOHOL ABSORPTION
JWatch General 1990;1990:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.